Breaking News
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% Upgrade now
Close

Sanofi ADR (SNYN)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
792.07 +12.07    +1.55%
04/10 - Closed. Currency in MXN ( Disclaimer )
  • Volume: 69
  • Bid/Ask: 750.22 / 900.00
  • Day's Range: 792.07 - 792.07
Type:  Equity
Market:  Mexico
ISIN:  US80105N1054 
S/N:  80105N105
Sanofi ADR 792.07 +12.07 +1.55%

SNYN Balance Sheet

 
Assess the latest Sanofi ADR balance sheet. Review the company's financial position, assess their current assets, liabilities and shareholder equity across the most recent periods (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Period Ending: 2022
30/06
Total Current Assets 28646 - - -
Cash and Short Term Investments 6899 - - -
Cash - - - -
Cash & Equivalents 6899 - - -
Short Term Investments - - - -
Total Receivables, Net 538 - - -
Accounts Receivables - Trade, Net - - - -
Total Inventory - - - -
Prepaid Expenses - - - -
Other Current Assets, Total 21209 - - -
Total Assets 121826 - - -
Property/Plant/Equipment, Total - Net 11642 - - -
Property/Plant/Equipment, Total - Gross - - - -
Accumulated Depreciation, Total - - - -
Goodwill, Net - - - -
Intangibles, Net 72533 - - -
Long Term Investments - - - -
Note Receivable - Long Term 538 - - -
Other Long Term Assets, Total 9005 - - -
Other Assets, Total 20671 - - -
Total Current Liabilities 22077 - - -
Accounts Payable 18233 - - -
Payable/Accrued - - - -
Accrued Expenses - - - -
Notes Payable/Short Term Debt 3063 - - -
Current Port. of LT Debt/Capital Leases 231 - - -
Other Current liabilities, Total 550 - - -
Total Liabilities 50522 - - -
Total Long Term Debt 17943 - - -
Long Term Debt 15942 - - -
Capital Lease Obligations 2001 - - -
Deferred Income Tax 1550 - - -
Minority Interest 353 - - -
Other Liabilities, Total 5536 - - -
Total Equity 71304 - - -
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 70951 - - -
Additional Paid-In Capital - - - -
Retained Earnings (Accumulated Deficit) - - - -
Treasury Stock - Common - - - -
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total 353 - - -
Total Liabilities & Shareholders' Equity 121826 - - -
Total Common Shares Outstanding - - - -
Total Preferred Shares Outstanding - - - -
* In Millions of (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

SNY Comments

Write your thoughts about Sanofi
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email